Genetic regulation of RNA splicing in human pancreatic islets.

Beta cells CTRB2 Diabetes pathophysiology G-protein signaling Pancreatic beta-cells Pancreatic islets Quantitative trait loci RNA splicing Senescence TWAS Type 1 diabetes Type 2 diabetes

Journal

Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660

Informations de publication

Date de publication:
15 09 2022
Historique:
received: 24 12 2021
accepted: 23 08 2022
entrez: 15 9 2022
pubmed: 16 9 2022
medline: 20 9 2022
Statut: epublish

Résumé

Non-coding genetic variants that influence gene transcription in pancreatic islets play a major role in the susceptibility to type 2 diabetes (T2D), and likely also contribute to type 1 diabetes (T1D) risk. For many loci, however, the mechanisms through which non-coding variants influence diabetes susceptibility are unknown. We examine splicing QTLs (sQTLs) in pancreatic islets from 399 human donors and observe that common genetic variation has a widespread influence on the splicing of genes with established roles in islet biology and diabetes. In parallel, we profile expression QTLs (eQTLs) and use transcriptome-wide association as well as genetic co-localization studies to assign islet sQTLs or eQTLs to T2D and T1D susceptibility signals, many of which lack candidate effector genes. This analysis reveals biologically plausible mechanisms, including the association of T2D with an sQTL that creates a nonsense isoform in ERO1B, a regulator of ER-stress and proinsulin biosynthesis. The expanded list of T2D risk effector genes reveals overrepresented pathways, including regulators of G-protein-mediated cAMP production. The analysis of sQTLs also reveals candidate effector genes for T1D susceptibility such as DCLRE1B, a senescence regulator, and lncRNA MEG3. These data expose widespread effects of common genetic variants on RNA splicing in pancreatic islets. The results support a role for splicing variation in diabetes susceptibility, and offer a new set of genetic targets with potential therapeutic benefit.

Sections du résumé

BACKGROUND
Non-coding genetic variants that influence gene transcription in pancreatic islets play a major role in the susceptibility to type 2 diabetes (T2D), and likely also contribute to type 1 diabetes (T1D) risk. For many loci, however, the mechanisms through which non-coding variants influence diabetes susceptibility are unknown.
RESULTS
We examine splicing QTLs (sQTLs) in pancreatic islets from 399 human donors and observe that common genetic variation has a widespread influence on the splicing of genes with established roles in islet biology and diabetes. In parallel, we profile expression QTLs (eQTLs) and use transcriptome-wide association as well as genetic co-localization studies to assign islet sQTLs or eQTLs to T2D and T1D susceptibility signals, many of which lack candidate effector genes. This analysis reveals biologically plausible mechanisms, including the association of T2D with an sQTL that creates a nonsense isoform in ERO1B, a regulator of ER-stress and proinsulin biosynthesis. The expanded list of T2D risk effector genes reveals overrepresented pathways, including regulators of G-protein-mediated cAMP production. The analysis of sQTLs also reveals candidate effector genes for T1D susceptibility such as DCLRE1B, a senescence regulator, and lncRNA MEG3.
CONCLUSIONS
These data expose widespread effects of common genetic variants on RNA splicing in pancreatic islets. The results support a role for splicing variation in diabetes susceptibility, and offer a new set of genetic targets with potential therapeutic benefit.

Identifiants

pubmed: 36109769
doi: 10.1186/s13059-022-02757-0
pii: 10.1186/s13059-022-02757-0
pmc: PMC9479353
doi:

Substances chimiques

Protein Isoforms 0
RNA, Long Noncoding 0
Proinsulin 9035-68-1
DCLRE1B protein, human EC 3.1.-
Exodeoxyribonucleases EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

196

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT101033
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L02036X/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200837/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom

Investigateurs

Miriam Cnop (M)
Lena Eliasson (L)
Jonathan Lou S Esguerra (JLS)
Décio L Eizirik (DL)
Leif Groop (L)
Thomas S Jensen (TS)
Torben Hansen (T)
Piero Marchetti (P)
Josep M Mercader (JM)
Hindrik Mulder (H)
Chris R Stabile-Barnett (CR)
Christian Thirion (C)
David Torrents (D)

Informations de copyright

© 2022. The Author(s).

Références

Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17921-6
pubmed: 24127591
Am J Hum Genet. 2021 Oct 7;108(10):1852-1865
pubmed: 34559995
Mol Cell Biol. 2017 Oct 27;37(22):
pubmed: 28847847
J Cell Biol. 2010 Mar 22;188(6):821-32
pubmed: 20308425
Nat Genet. 2016 Mar;48(3):245-52
pubmed: 26854917
Nat Commun. 2020 Sep 30;11(1):4912
pubmed: 32999275
Biochem Biophys Res Commun. 2016 Sep 23;478(3):1028-34
pubmed: 27507217
Nat Methods. 2015 Nov;12(11):1061-3
pubmed: 26366987
Nat Genet. 2019 Jul;51(7):1137-1148
pubmed: 31253982
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Nature. 2019 Jun;570(7759):71-76
pubmed: 31118516
Science. 2016 Apr 29;352(6285):600-4
pubmed: 27126046
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):13924-9
pubmed: 25201977
Genome Res. 2017 Feb;27(2):208-222
pubmed: 27864352
Nat Genet. 2014 Feb;46(2):136-143
pubmed: 24413736
Physiol Rev. 2018 Jan 1;98(1):117-214
pubmed: 29212789
Cell Metab. 2016 Oct 11;24(4):608-615
pubmed: 27667665
J Proteome Res. 2019 Feb 1;18(2):623-632
pubmed: 30450911
Nat Genet. 2022 Mar;54(3):251-262
pubmed: 35288711
Transplantation. 2010 May 15;89(9):1154-60
pubmed: 20098354
J Biol Chem. 2006 Aug 4;281(31):21942-21953
pubmed: 16731532
Nat Genet. 2018 Sep;50(9):1327-1334
pubmed: 30127527
Diabetes Obes Metab. 2017 Sep;19 Suppl 1:42-53
pubmed: 28466587
Int J Mol Sci. 2019 Sep 26;20(19):
pubmed: 31561444
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D433-7
pubmed: 15608232
Genetics. 2014 Oct;198(2):497-508
pubmed: 25104515
J Diabetes Investig. 2013 Sep 13;4(5):426-7
pubmed: 24843690
Nat Genet. 2012 Mar 18;44(4):369-75, S1-3
pubmed: 22426310
Mol Cell Biol. 2014 Apr;34(7):1290-9
pubmed: 24469402
Bioinformatics. 2016 Jan 15;32(2):283-5
pubmed: 26395773
Bioinformatics. 2017 Sep 01;33(17):2776-2778
pubmed: 28475694
Curr Opin Pharmacol. 2017 Dec;37:24-28
pubmed: 28822846
Nucleic Acids Res. 2013 Jan;41(Database issue):D808-15
pubmed: 23203871
Science. 2020 Sep 11;369(6509):1318-1330
pubmed: 32913098
Nature. 2021 Jun;594(7863):398-402
pubmed: 34012112
Lancet Diabetes Endocrinol. 2021 Aug;9(8):525-544
pubmed: 34181914
Nat Genet. 2016 Jul;48(7):709-17
pubmed: 27182965
PLoS Genet. 2015 Dec 01;11(12):e1005694
pubmed: 26624892
Nat Genet. 2018 Jan;50(1):151-158
pubmed: 29229983
Mol Endocrinol. 2008 Apr;22(4):781-98
pubmed: 18174356
Nat Genet. 2019 Apr;51(4):592-599
pubmed: 30926968
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Cell Rep. 2021 Oct 12;37(2):109807
pubmed: 34644572
Transplantation. 2005 Jan 15;79(1):91-7
pubmed: 15714175
Diabetologia. 2021 Jun;64(6):1342-1347
pubmed: 33830302
Nat Genet. 2019 Jun;51(6):973-980
pubmed: 31133750
Cell. 2009 Feb 20;136(4):701-18
pubmed: 19239890
Nat Genet. 2022 May;54(5):560-572
pubmed: 35551307
Bioinformatics. 2015 Mar 1;31(5):782-4
pubmed: 25338720
Diabetes. 2018 Sep;67(9):1807-1815
pubmed: 30084829
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
J Cell Physiol. 2016 Apr;231(4):852-62
pubmed: 26313443
Nat Genet. 2000 Aug;25(4):406-9
pubmed: 10932183
Am J Hum Genet. 2012 Nov 2;91(5):839-48
pubmed: 23103226
Am J Hum Genet. 2020 Feb 6;106(2):188-201
pubmed: 31978332
Nat Rev Genet. 2014 Oct;15(10):689-701
pubmed: 25112293
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2301-2306
pubmed: 28193859
Nat Genet. 2019 Feb;51(2):343-353
pubmed: 30692680
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
Nat Genet. 2018 Nov;50(11):1505-1513
pubmed: 30297969
FASEB J. 2019 Apr;33(4):4716-4728
pubmed: 30589572
Nat Genet. 2020 Jul;52(7):680-691
pubmed: 32541925
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Methods. 2015 Oct;12(10):931-4
pubmed: 26301843
Nat Genet. 2021 Jun;53(6):840-860
pubmed: 34059833
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D590-8
pubmed: 16381938
Sci Signal. 2018 Jun 26;11(536):
pubmed: 29945883
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Nat Genet. 2021 Jul;53(7):962-971
pubmed: 34127860
Cell Metab. 2019 May 7;29(5):1045-1060.e10
pubmed: 30799288
Diabetes. 2020 Mar;69(3):477-483
pubmed: 31882561
Cell. 2017 Oct 5;171(2):321-330.e14
pubmed: 28965763
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
J Biol Chem. 2013 Apr 26;288(17):11887-96
pubmed: 23486476
Cell Transplant. 2010;19(8):1031-46
pubmed: 20546673
Nat Genet. 2016 Nov;48(11):1443-1448
pubmed: 27694958
Nat Genet. 2015 Aug;47(8):856-60
pubmed: 26121088
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10097-102
pubmed: 20479256
Nat Genet. 2010 Mar;42(3):255-9
pubmed: 20118932
Endocrinology. 2011 Jul;152(7):2599-608
pubmed: 21540283
J Am Soc Nephrol. 2014 Mar;25(3):574-86
pubmed: 24204001
Science. 1991 Dec 20;254(5039):1762-7
pubmed: 1763325
Science. 2020 Sep 11;369(6509):
pubmed: 32913075
J Biol Chem. 2014 Apr 4;289(14):9611-22
pubmed: 24550399
Cell Metab. 2016 Oct 11;24(4):593-607
pubmed: 27667667
Elife. 2018 Feb 07;7:
pubmed: 29412141
Nat Genet. 2019 Nov;51(11):1588-1595
pubmed: 31676868
PLoS Genet. 2012;8(3):e1002552
pubmed: 22412385
Nat Rev Genet. 2016 Jan;17(1):19-32
pubmed: 26593421
Bioinformatics. 2015 Aug 15;31(16):2601-6
pubmed: 25886982
Nat Rev Endocrinol. 2021 Mar;17(3):162-175
pubmed: 33495605
Diabetes. 2014 Aug;63(8):2888-94
pubmed: 24696446
Diabetologia. 2015 May;58(5):1138-40
pubmed: 25697163
Nat Commun. 2017 May 18;8:15452
pubmed: 28516912
Diabetes. 2014 Oct;63(10):3557-64
pubmed: 24848070

Auteurs

Goutham Atla (G)

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Centro de Investigación Biomédica en red Diabetes y enfermedades metabólicas asociadas (CIBERDEM), Barcelona, Spain.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

Silvia Bonàs-Guarch (S)

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain. silvia.bonas@crg.eu.
Centro de Investigación Biomédica en red Diabetes y enfermedades metabólicas asociadas (CIBERDEM), Barcelona, Spain. silvia.bonas@crg.eu.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. silvia.bonas@crg.eu.

Mirabai Cuenca-Ardura (M)

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Centro de Investigación Biomédica en red Diabetes y enfermedades metabólicas asociadas (CIBERDEM), Barcelona, Spain.

Anthony Beucher (A)

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Centro de Investigación Biomédica en red Diabetes y enfermedades metabólicas asociadas (CIBERDEM), Barcelona, Spain.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

Daniel J M Crouch (DJM)

JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.

Javier Garcia-Hurtado (J)

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Centro de Investigación Biomédica en red Diabetes y enfermedades metabólicas asociadas (CIBERDEM), Barcelona, Spain.

Ignasi Moran (I)

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
Present Address: Life Sciences Department, Barcelona Supercomputing Center (BSC), 08034, Barcelona, Spain.

Manuel Irimia (M)

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.

Rashmi B Prasad (RB)

Lund University Diabetes Centre, Clinical Research Center, Malmö, Sweden.
Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.

Anna L Gloyn (AL)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Department of Pediatrics, Division of Endocrinology, Stanford School of Medicine, Stanford, CA, USA.

Lorella Marselli (L)

Department of Clinical and Experimental Medicine, AOUP Cisanello University Hospital, University of Pisa, Pisa, Italy.

Mara Suleiman (M)

Department of Clinical and Experimental Medicine, AOUP Cisanello University Hospital, University of Pisa, Pisa, Italy.

Thierry Berney (T)

Cell Isolation and Transplantation Center, University of Geneva, Geneva, Switzerland.

Eelco J P de Koning (EJP)

Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Hubrecht Institute/KNAW, Utrecht, the Netherlands.

Julie Kerr-Conte (J)

University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Lille (CHU Lille), Institute Pasteur Lille, U1190 -European Genomic Institute for Diabetes (EGID), F59000, Lille, France.

Francois Pattou (F)

University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Lille (CHU Lille), Institute Pasteur Lille, U1190 -European Genomic Institute for Diabetes (EGID), F59000, Lille, France.

John A Todd (JA)

JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.

Lorenzo Piemonti (L)

Diabetes Research Institute, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.

Jorge Ferrer (J)

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain. jorge.ferrer@crg.eu.
Centro de Investigación Biomédica en red Diabetes y enfermedades metabólicas asociadas (CIBERDEM), Barcelona, Spain. jorge.ferrer@crg.eu.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. jorge.ferrer@crg.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH